Login to Your Account



EUROPE NEWS

LONDON – Drug discovery in the U.K. needs to be radically reshaped, ditching "irrelevant" animal models in favor of more testing on human tissues and cells, according to a new report by the Medicines Discovery Catapult (MDC).

DUBLIN – The European biotechnology sector enjoyed a period of sustained investor appetite in 2017, reflecting its ongoing ability to tap into global equity markets in order to fund development of its pipeline. Total investment reached $6.85 billion in disclosed transactions involving drug development firms.

DUBLIN – Enterome SA raised €32 million (US$38.6 million) in a series D financing round and secured access to another €40 million through a loan facility with the European Investment Bank (EIB), which gives it more than enough firepower to complete proof-of-concept trials of its lead drug candidates in Crohn's disease and in cancer.

More EUROPE Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: